RxDoctor Payments Data

Buddy Hurt, DO

Family Medicine · Versailles, KYNPI 1366479248

Payments from drug & device makers

$251in general payments, 2019–2025

Across 14 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$66
  • Ultragenyx Pharmaceutical Inc.$42
  • Pfizer$25
  • Astellas Pharma US Inc$20
  • Lilly USA, LLC$19
  • Boehringer Ingelheim$19
  • plus $61 from 4 others

What the payments were for

  • Food & beverage$251100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$251 in reported general payments places this provider in the 30th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$90,906
Medicare patients
329
Services billed
1,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide99$134,790
EliquisApixaban52$60,247
MounjaroTirzepatide32$41,985
RybelsusSemaglutide13$26,030
JardianceEmpagliflozin24$25,309
FarxigaDapagliflozin Propanediol33$25,048
XareltoRivaroxaban21$23,969
ShingrixVaricella-Zoster Ge/As01b/Pf38$8,426
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$7,340
SymbicortBudesonide/Formoterol Fumarate14$5,772
Varenicline Tartrate19$4,534
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$3,908
Albuterol Sulfate HfaAlbuterol Sulfate101$2,633
Boostrix TdapDiphth,pertuss(Acell),tet Vac28$1,937
Levothyroxine Sodium163$1,924

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$14$160,820112 claims
PfizerEliquis$25$60,24752 claims
Lilly USA, LLCMounjaro$19$41,98532 claims
Boehringer IngelheimJardiance$19$25,30924 claims
GSKShingrix$16$8,42638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Versailles

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →